Related Experiment Video
Updated: May 9, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA-145 function as a cell growth repressor by directly targeting c-Myc in human ovarian cancer
Wenjing Zhang1, Qian Wang, Minglian Yu
1Department of Gynecology and Obstetrics, The Military General Hospital of Beijing PLA, No. 5 Nan Men Cang, Dongcheng District, Beijing 100700, PR China. wanghuibjing@sina.cn.
Abstract:
MiR-145 is reported to be significantly down-regulated in ovarian cancer. This study was aimed at elucidating the roles of miR-145 in regulating the biological behavior of epithelial ovarian cancer (EOC) cells. In this report, we find out that up-regulation of miR-145 in OVCAR-3 and SKOV-3 cells inhibit cell proliferation and promote cell apoptosis. We show that miR-145 directly target the c-Myc 3'-UTR. Moreover, ectopic expression of c-Myc reduces the inhibition of cell proliferation caused by miR-145 transfection. Cell cycle assay showed that up-regulation of miR-145 reduces S phase population, and restoration of c-Myc can rescue this reduction. These findings indicate that miR-145 inhibits cell proliferation and promotes cell apoptosis by targeting c-Myc 3'-UTR. Therefore, the result indicated that miR- 145 could be used as a potential therapeutic target in ovarian cancer.
Insights
MicroRNA-145 (miR-145) is down-regulated in ovarian cancer. Restoring miR-145 inhibits cancer cell growth and promotes cell death by targeting c-Myc, suggesting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ovarian cancer is a significant health concern with limited effective treatments.
- MicroRNA-145 (miR-145) has been observed to be downregulated in ovarian cancer tissues.
- Understanding the specific roles of miR-145 in epithelial ovarian cancer (EOC) is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the functional role of miR-145 in regulating the biological behavior of epithelial ovarian cancer (EOC) cells.
- To determine the molecular mechanism by which miR-145 exerts its effects on EOC cells.
- To evaluate the potential of miR-145 as a therapeutic target for ovarian cancer.
Main Methods:
- Transfection of miR-145 mimics into OVCAR-3 and SKOV-3 EOC cell lines.
- Cell proliferation assays (e.g., MTT assay).
- Apoptosis assays (e.g., flow cytometry).
- Western blotting to assess protein expression levels.
- Luciferase reporter assays to confirm direct targeting of c-Myc.
- Cell cycle analysis.
Main Results:
- Up-regulation of miR-145 significantly inhibited cell proliferation and induced apoptosis in OVCAR-3 and SKOV-3 cells.
- miR-145 was found to directly target the 3'-untranslated region (3'-UTR) of c-Myc mRNA.
- Ectopic expression of c-Myc partially rescued the inhibitory effect of miR-145 on cell proliferation.
- miR-145 transfection led to a reduction in the S phase cell population, which was reversed by c-Myc restoration.
Conclusions:
- miR-145 functions as a tumor suppressor in epithelial ovarian cancer.
- The anti-proliferative and pro-apoptotic effects of miR-145 are mediated through direct targeting of c-Myc.
- miR-145 represents a promising molecular target for the development of novel therapeutic interventions for ovarian cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic cells are...
Abnormal Proliferation
